Monash IVF says the number of new patient registrations and its market share have fallen in the first four months of the fiscal year as the fertility group battles to repair its reputation following two separate embryo transfer mix-ups at its clinics in Melbourne and Brisbane.
The company told shareholders on Thursday that full-year earnings were now expected at the bottom end of its forecast $20 million to $23 million range due to weaker-than-expected performance between July and October.
Loading…
